Medical Unit-than-expected Performance Of The Pharmaceutical Industry Is Generally Optimistic

Recently, the Ministry of Health and other five ministries jointly issued "on the

pilot reform of public hospitals guidance." Industry analysts generally believe that the "opinions" issued, marking the year through the 2009-2020 " The new medical reform "Full open. This will help optimize the industrial chain competition order Medicine Industry's future "golden years" of growth prospects are very clear.

Recently, an ice-breaking reforms in public hospitals under the influence of the favorable policies, pharmaceutical stocks have also been released through the 2009 annual report showed the superior performance. At the same time the overall stock market weakness is also the case, revealing their own defensive.

Brokerage funds in the major recent reports or statements, promising pharmaceutical industry has basically become the consensus body. TX Gu statistics show that the fourth quarter of 2009, the Fund, the pharmaceutical industry to become the largest range of fund holdings of one of the industries. Many in the industry believe that the positive consumption structure of China's economic transition times, the future government will be further introduced to increase income and stimulate consumption, private investment and opening up policy, to benefit from China's economic restructuring, the explosive growth opportunities will focus on the consumer related industries.

Guoxin Securities researcher of that first half of 2009 about 25% of the pharmaceutical sector is forecasted to go, the fourth quarter, third quarter results continued the trend growth rate improved significantly in 2009, the year pre-medical sector will reach more than 30% by the company as a whole performance continues to improve, Jinling Pharmaceutical (12.57,0.08,0.64%), Ma Ying-long (42.40, -0.19, -0.45%), Shanghai Pharmaceutical (14.73,0.00,0.00%), and other key company performance increase is expected to exceed 100%. Pharmaceutical companies from the latest annual report released data shows that pharmaceutical companies are very excellent performance in 2009.

Report shows that suburban district of Hangzhou (14.93, -0.58, -3.74%) growth in 2009, faster performance, enhance profitability. The company in 2009 operating income 15.338657 billion yuan, up 83.62 percent; to achieve operating profit 52,844,900 yuan, up 190.72 percent; net profit 46.4225 million yuan, up 198.59 percent; achieve diluted earnings per share 0.32 yuan. Hengrui Medicine (49.16,0.05,0.10%) in 2009 maintained a high growth business performance. Company revenues of 3.029 billion yuan in 2009, increased by 6.4 billion yuan, up 26.6%, net profit of 693 million yuan, an increase of 2.6 billion yuan, up 59.16 percent. Kehua organisms (24.62,0.00,0.00%) in 2009 23% of steady growth performance, total revenue of 621 million yuan, operating profit 220 million yuan, net profit attributable to shareholders of the parent 204 million, respectively, up 27.57 percent over the previous year, 28.27%, 22.83%. 042 million yuan net profit attributable to shareholders of the parent, up 44%. In addition, 39 medical (24.78,0.70,2.91%) released results of Letters show of 2009 Sell Income of 4.85 billion, up 12.43%; net profit of 709 million up 41.86%; to achieve earnings per share of 0.72 yuan.

Industry also believe that the pharmaceutical industry sales in 2010 are expected to maintain a growth rate of over 20% profit growth to maintain more than 25%. 2009 is the first year of our new health care reform in 2010, the pharmaceutical industry will become a new beginning.

"The pharmaceutical industry over the next decade will be the golden period of development." Guoxin Securities researcher believes that the reform of public hospitals are indeed affect the body, the pilot on the upper reaches of the impact of pharmaceutical industry is gradual, less short-term impact. However, the reform of public hospitals is, after all, is a system, long-term project, the final result will be to gradually pulling upstream pharmaceutical industry, medicine, commercial enterprises and competition structure. Introduction of each policy are an industry reshuffle is conducive to high-quality leading enterprise business segment strong strong Always the Winner Always the Winner.

In addition, national security researchers believe that the "new medical reform" will be good private hospital. Encourage social capital to enter the field of health care services to this policy, means that the future will reduce the proportion of public hospitals, which can bring a large number of acquisitions of medical resources. Meanwhile, the private hospital Medicare As subsidies will be better competition than the original treatment.

by: gaga

POST COMMENT

Drug Rehab Florida - Regain Control Of Your Life! Natural Eczema Treatment - Why Regular Medicine Just Won't Do the Trick Anymore Acyclovir Drug Uses And Information Advancing Medical Management Software Understanding The Drug Abuse Process A Drug Rehab Center Is The Best Place To Recover From Substance Dependency Medical Information Concerning Ativan Claiming Compensation for Medical Negligence Learn About Drug Addiction And Drug Abuse Treatment Saliva Drug Test - An Effective Method to Detect the Case of Drug Abuse Alarming Drug Abuse Statistics It's Time to Pay Attention to the Risks of Prescription Drug Abuse Drug Abuse - Do Not Wait, Get Facilitate Now